Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2020 Dec;109(12):1531-1539.
doi: 10.1007/s00392-020-01722-w. Epub 2020 Aug 11.

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Affiliations
Multicenter Study

COVID-19 among heart transplant recipients in Germany: a multicenter survey

Rasmus Rivinius et al. Clin Res Cardiol. 2020 Dec.

Abstract

Aims: Heart transplantation may represent a particular risk factor for severe coronavirus infectious disease 2019 (COVID-19) due to chronic immunosuppression and frequent comorbidities. We conducted a nation-wide survey of all heart transplant centers in Germany presenting the clinical characteristics of heart transplant recipients with COVID-19 during the first months of the pandemic in Germany.

Methods and results: A multicenter survey of all heart transplant centers in Germany evaluating the current status of COVID-19 among adult heart transplant recipients was performed. A total of 21 heart transplant patients with COVID-19 was reported to the transplant centers during the first months of the pandemic in Germany. Mean patient age was 58.6 ± 12.3 years and 81.0% were male. Comorbidities included arterial hypertension (71.4%), dyslipidemia (71.4%), diabetes mellitus (33.3%), chronic kidney failure requiring dialysis (28.6%) and chronic-obstructive lung disease/asthma (19.0%). Most patients received an immunosuppressive drug regimen consisting of a calcineurin inhibitor (71.4%), mycophenolate mofetil (85.7%) and steroids (71.4%). Eight of 21 patients (38.1%) displayed a severe course needing invasive mechanical ventilation. Those patients showed a high mortality (87.5%) which was associated with right ventricular dysfunction (62.5% vs. 7.7%; p = 0.014), arrhythmias (50.0% vs. none; p = 0.012), and thromboembolic events (50.0% vs. none; p = 0.012). Elevated high-sensitivity cardiac troponin T- and N-terminal prohormone of brain natriuretic peptide were significantly associated with the severe form of COVID-19 (p = 0.017 and p < 0.001, respectively).

Conclusion: Severe course of COVID-19 was frequent in heart transplanted patients. High mortality was associated with right ventricular dysfunction, arrhythmias, thromboembolic events, and markedly elevated cardiac biomarkers.

Keywords: COVID-19; Heart transplantation; Immunosuppression; Mortality.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

References

    1. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
    1. Böhm M, Frey N, Giannitsis E, Sliwa K, Zeiher AM (2020) Coronavirus Disease 2019 (COVID-19) and its implications for cardiovascular care: expert document from the German Cardiac Society and the World Heart Federation. Clin Res Cardiol 1–14. 10.1007/s00392-020-01656-3 - PMC - PubMed
    1. Rattka M, Baumhardt M, Dreyhaupt J, et al. (2020) 31 days of COVID-19-cardiac events during restriction of public life-a comparative study. Clin Res Cardiol 1–7. 10.1007/s00392-020-01681-2 - PMC - PubMed
    1. Rath D, Petersen-Uribe Á, Avdiu A, et al. (2020) Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection. Clin Res Cardiol 1–9. 10.1007/s00392-020-01683-0 - PMC - PubMed
    1. Van Camp G, De Beenhouwer H, Beles M, et al. (2020) Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution. Clin Res Cardiol 1–4. 10.1007/s00392-020-01686-x - PMC - PubMed

Publication types

MeSH terms

Substances